Analyzing incomplete longitudinal clinical trial data

Type: Article

Publication Date: 2004-07-01

Citations: 343

DOI: https://doi.org/10.1093/biostatistics/kxh001

Abstract

Using standard missing data taxonomy, due to Rubin and co‐workers, and simple algebraic derivations, it is argued that some simple but commonly used methods to handle incomplete longitudinal clinical trial data, such as complete case analyses and methods based on last observation carried forward, require restrictive assumptions and stand on a weaker theoretical foundation than likelihood‐based methods developed under the missing at random (MAR) framework. Given the availability of flexible software for analyzing longitudinal sequences of unequal length, implementation of likelihood‐based MAR analyses is not limited by computational considerations. While such analyses are valid under the comparatively weak assumption of MAR, the possibility of data missing not at random (MNAR) is difficult to rule out. It is argued, however, that MNAR analyses are, themselves, surrounded with problems and therefore, rather than ignoring MNAR analyses altogether or blindly shifting to them, their optimal place is within sensitivity analysis. The concepts developed here are illustrated using data from three clinical trials, where it is shown that the analysis method may have an impact on the conclusions of the study.

Locations

Similar Works

Action Title Year Authors
+ PDF Chat Analyzing incomplete longitudinal clinical trial data 2004 Geert Molenberghs
Herbert Thijs
Ivy Jansen
Caroline Beunckens
Michael G. Kenward
Craig Mallinckrodt
Raymond J. Carroll
+ PDF Chat Analyzing Incomplete Discrete Longitudinal Clinical Trial Data 2006 Ivy Jansen
Caroline Beunckens
Geert Molenberghs
Geert Verbeke
Craig Mallinckrodt
+ Analyzing Longitudinal Clinical Trial Data: A Practical Guide 2016 Craig Mallinckrodt
Ilya Lipkovich
+ PDF Chat Assessing Response Profiles from Incomplete Longitudinal Clinical Trial Data Under Regulatory Considerations 2003 Craig Mallinckrodt
W. Scott Clark
Raymond J. Carroll
Geert Molenberghs
+ PDF Chat LONGITUDINAL AND INCOMPLETE CLINICAL STUDIES 2009 Geert Molenberghs
Geert Verbeke
+ Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide 2013 Craig Mallinckrodt
+ Preventing and Treating Missing Data in Longitudinal Clinical Trials 2013 Craig Mallinckrodt
+ Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study 2006 M. Liu
Longsheng Wei
J. Zhang
+ Choice of the primary analysis in longitudinal clinical trials 2004 Craig Mallinckrodt
John G. Watkin
Geert Molenberghs
Raymond J. Carroll
+ Analyzing longitudinal clinical trial data with nonignorable missingness and unknown missingness reasons 2010 Hui Xie
+ PDF Chat Addressing Missing Data in Clinical Trials 2011 Thomas R. Fleming
+ Statistical analysis of longitudinal randomized clinical trials with missing data : a comparison of approaches 2015 Royes Joseph
+ Assessing and interpreting treatment effects in longitudinal clinical trials with missing data 2003 Craig Mallinckrodt
T.M. Sanger
Sanjay Dubé
David J. DeBrota
Geert Molenberghs
Raymond J. Carroll
William Z. Potter
Gary D. Tollefson
+ Conceptual Considerations regarding Endpoints, Hypotheses, and Analyses for Incomplete Longitudinal Clinical Trial Data 2009 Craig Mallinckrodt
Michael G. Kenward
+ Small sample longitudinal clinical trial with missing data: A comparison of analytic methods. 1999 Kevin Delucchi
Alan Bostrom
+ Small sample longitudinal clinical trial with missing data: A comparison of analytic methods. 1999 Kevin Delucchi
Alan Bostrom
+ PDF Chat Missing Data 2006 Geert Molenberghs
Emmanuel Lesaffre
+ Missing Data 2005 Geert Molenberghs
Emmanuel Lesaffre
+ Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials 2005 Caroline Beunckens
Geert Molenberghs
Michael G. Kenward
+ Sample size calculations with multiplicity adjustment for longitudinal clinical trials with missing data 2011 Kaifeng Lu

Works That Cite This (157)

Action Title Year Authors
+ PDF Chat <i>D</i>‐optimal designs for multiarm trials with dropouts 2019 Kim May Lee
Stefanie Biedermann
Robin Mitra
+ PDF Chat A hidden Markov model for informative dropout in longitudinal response data with crisis states 2011 Alessandra Spagnoli
Robin Henderson
Richard J. Boys
Jeanine J. Houwing‐Duistermaat
+ Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis 2013 Jos W. R. Twisk
Michiel R. de Boer
Wieke de Vente
Martijn W. Heymans
+ PDF Chat A Dirichlet Process Mixture Model for Non-Ignorable Dropout 2019 Camille M. Moore
Nichole E. Carlson
Samantha MaWhinney
Sarah M. Kreidler
+ PDF Chat A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials 2014 Rita Faria
Manuel Gomes
David Epstein
Ian R. White
+ Comparison of data analysis strategies for intent-to-treat analysis in pre-test–post-test designs with substantial dropout rates 2008 Agus Salim
Andrew Mackinnon
Helen Christensen
Kathleen M Griffiths
+ On the practical application of mixed effects models for repeated measures to clinical trial data 2012 Scott W. Andersen
Brian A. Millen
+ Consideration of the adaptive randomization allocation ratio in the presence of treatment group heteroscedasticity in clinical trials 2022 Jiashen Lu
Yeh‐Fong Chen
+ Last Observation Carried Forward: A Crystal Ball? 2009 Michael G. Kenward
Geert Molenberghs
+ Handling Baselines in Repeated Measures Analyses with Missing Data at Random 2011 Phillip Dinh
Peiling Yang